This avoided any influx of poor prognostic high-grade serous carcinomas, demonstrated by the low prevalence of combined WT1 expression and abnormal p53 expression [10] (only one case in the current cohort expressed this combination, but showed typical endometrioid morphology). The gene discussed is WT1; the disease is serous adenocarcinoma.